1-2 of 2
Habermehl Christina, PhD
Close
Sort by
Journal Articles

Salvage Autologous Transplant and Lenalidomide Maintenance Versus Continuous Lenalidomide/Dexamethasone for Relapsed Multiple Myeloma: Results of the Randomized GMMG Phase III Multicenter Trial Relapse

Hartmut Goldschmidt, MD, Marc-A. Baertsch, MD, Jana Schlenzka, MD, Natalia Becker, PhD, Habermehl Christina, PhD, Thomas Hielscher, Marc S Raab, MD, Jens Hillengass, MD, Carsten Müller-Tidow, MD, Steffen Luntz, MD, Anna Jauch, PhD, Peter Brossart, MD, Martin Goerner, MD, Stefan A Klein, MD, Martin Schmidt-Hieber, MD PhD, Peter Reimer, MD, Ullrich Graeven, MD, Roland Fenk, MD PhD, Mathias Haenel, MD, Hans Martin, MD, Hans-Walter Lindemann, MD, Christoph Scheid, MD, Axel Nogai, MD, Hans Jürgen Salwender, MD, Richard Noppeney, MD, Katja Weisel, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 253.
https://doi.org/10.1182/blood-2018-99-111203
Published: 2018
Journal Articles

Subgroup Analyses of the Randomized GMMG Phase III Multicenter Trial Relapse Suggest Survival Benefit of Salvage Autologous Transplant Primarily in Low Risk Multiple Myeloma

Marc-A. Baertsch, MD, Jana Schlenzka, MD, Habermehl Christina, PhD, Thomas Hielscher, Marc S Raab, MD, Jens Hillengass, MD, Carsten Müller-Tidow, MD, Steffen Luntz, MD, Anna Jauch, PhD, Peter Brossart, MD, Martin Goerner, MD, Stefan A Klein, MD, Martin Schmidt-Hieber, MD PhD, Peter Reimer, MD, Ullrich Graeven, MD, Roland Fenk, MD PhD, Mathias Haenel, MD, Hans Martin, MD, Hans-Walter Lindemann, MD, Christoph Scheid, MD, Axel Nogai, MD, Hans Jürgen Salwender, MD, Richard Noppeney, MD, Katja Weisel, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 254.
https://doi.org/10.1182/blood-2018-99-119762
Published: 2018